Unknown

Dataset Information

0

Long-Term Immunogenicity upon Pertussis Booster Vaccination in Young Adults and Children in Relation to Priming Vaccinations in Infancy.


ABSTRACT: Booster vaccinations for pertussis are advised in many countries during childhood or adulthood. In a phase IV longitudinal interventional study, we assessed long-term immunity following an extra pertussis booster vaccination in children and adults. Children (9 years of age) were primed in infancy with either the Dutch whole cell pertussis (wP) vaccine (n = 49) or acellular pertussis (aP) vaccines (n = 59), and all children received a preschool aP booster. Adults (25-29 years, n = 86) were wP-primed in infancy and did not receive a preschool booster. All were followed-up for approximately 6 years. After the additional booster, antibody responses to pertussis were more heterogeneous but generally higher in adults compared with children, and additional modelling showed that antibody concentrations remained higher for at least a decade. Serologic parameters indicative of recent pertussis infection were more often found in aP-primed children (12%) compared with wP-primed individuals (2%) (p = 0.052). This suggests that the aP booster vaccination in aP-primed children offers less long-term protection against pertussis infection and consequently against transmission. Together, these data show that aP priming in combination with aP boosting may not be sufficient to prevent circulation and transmission, while wP-primed adults may benefit from enhanced long-lasting immunity.

SUBMITTER: Versteegen P 

PROVIDER: S-EPMC9146390 | biostudies-literature | 2022 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Long-Term Immunogenicity upon Pertussis Booster Vaccination in Young Adults and Children in Relation to Priming Vaccinations in Infancy.

Versteegen Pauline P   Bonačić Marinović Axel A AA   van Gageldonk Pieter G M PGM   van der Lee Saskia S   Hendrikx Lotte H LH   Sanders Elisabeth A M EAM   Berbers Guy A M GAM   Buisman Anne-Marie AM  

Vaccines 20220428 5


Booster vaccinations for pertussis are advised in many countries during childhood or adulthood. In a phase IV longitudinal interventional study, we assessed long-term immunity following an extra pertussis booster vaccination in children and adults. Children (9 years of age) were primed in infancy with either the Dutch whole cell pertussis (wP) vaccine (<i>n</i> = 49) or acellular pertussis (aP) vaccines (<i>n</i> = 59), and all children received a preschool aP booster. Adults (25-29 years, <i>n<  ...[more]

Similar Datasets

| S-EPMC11621984 | biostudies-literature
| S-EPMC9716536 | biostudies-literature
| S-EPMC8878388 | biostudies-literature
| S-EPMC4321240 | biostudies-literature
| S-EPMC8244209 | biostudies-literature
| S-EPMC9744953 | biostudies-literature
2012-10-01 | GSE39017 | GEO
| S-EPMC7654036 | biostudies-literature
2012-10-01 | E-GEOD-39017 | biostudies-arrayexpress
| S-EPMC390206 | biostudies-literature